MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis with £6.3m Series A funding round.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford Brain Diagnostics sets out with the goal of improving the treatment of Alzheimer’s by enabling early and accurate detection
The Oxford University spinout company launches to look inside the brain for novel markers of disease.
The visual data exploration company charges up for next stage of its evolution.
Osage University Partners and Oxford University Innovation sign MoU on investment into Oxford University spinouts.
Blue Water Vaccines, developing universal flu vaccine, completes $7m financing following successful preclinical study
Vaccine based on pioneering mathematical models, research from University of Oxford.
Virology spinout Theolytics emerges from stealth with £2.5m seed and Dr Ken Powell as chair.
Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at Oxford University
Samsung’s investment will enable Oxford Semantics to bring its powerful data integration and reasoning engine to more clients.